|
Real-time Estimate
Cboe BZX
01:29:37 11/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 159.61 USD | +1.70% |
|
-2.90% | +73.94% |
| 09:34pm | Berenberg Notes AstraZeneca's 'Stellar' Tozorakimab Late-stage Data; Buy Retained | MT |
| 09:10pm | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
| Market Cap | 24TCr 21TCr 20TCr 18TCr 34TCr 23,40100Cr 34TCr 2,36500Cr 91TCr 11,86900Cr 92TCr 90TCr 37,70000Cr | P/E 2026 * |
20.3x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 26TCr 23TCr 21TCr 20TCr 37TCr 25,26000Cr 37TCr 2,55300Cr 98TCr 12,81200Cr 99TCr 97TCr 40,69600Cr | EV / Sales 2026 * |
4.17x | EV / Sales 2027 * | 3.83x |
| Free-Float |
96.63% | Yield 2026 * |
2.12% | Yield 2027 * | 2.26% |
Last Transcript : AstraZeneca PLC
| 1 day | +1.69% | ||
| Current month | +72.37% | ||
| Current year | +73.94% |
| Current year | 89.04 |  | 160.3 |
| 1 year | 72.9 | | 160.3 |
| 3 years | 60.47 | | 160.3 |
| 5 years | 52.65 | | 160.3 |
| 10 years | 25.55 | | 160.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -2.90% | - | - | 24TCr | |
| -0.19% | -2.86% | +49.27% | +89.14% | 1,00200Cr | |
| -0.29% | -4.24% | +51.67% | +63.91% | 64TCr | |
| +1.71% | -2.38% | +20.02% | +70.43% | 44TCr | |
| -0.63% | -3.09% | +29.84% | +36.08% | 34TCr | |
| +0.43% | -14.61% | +11.32% | +26.98% | 26TCr | |
| +0.93% | -3.19% | -1.31% | +11.96% | 24TCr | |
| -2.30% | -13.65% | +37.69% | +46.53% | 21TCr | |
| -0.90% | -5.06% | -18.47% | -58.14% | 20TCr | |
| -0.60% | -4.19% | +25.72% | +88.07% | 18TCr | |
| Average | +0.14% | -5.00% | +22.86% | +41.66% | 39.22TCr | |
| Weighted average by Cap. | +0.16% | -4.24% | +32.11% | +56.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.33TCr 5.44TCr 5.14TCr 4.68TCr 8.75TCr 6,05200Cr 8.83TCr 61TCr 24TCr 3,07000Cr 24TCr 23TCr 9,75000Cr | 6.69TCr 5.75TCr 5.43TCr 4.95TCr 9.24TCr 6,39600Cr 9.33TCr 65TCr 25TCr 3,24400Cr 25TCr 25TCr 10,30400Cr |
| Net income | 1.2TCr 1.03TCr 975.84Cr 888.99Cr 1.66TCr 1,15000Cr 1.68TCr 12TCr 4.47TCr 58TCr 4.52TCr 4.42TCr 1,85200Cr | 1.38TCr 1.18TCr 1.12TCr 1.02TCr 1.9TCr 1,31600Cr 1.92TCr 13TCr 5.12TCr 67TCr 5.17TCr 5.06TCr 2,12100Cr |
| Net Debt | 1.95TCr 1.67TCr 1.58TCr 1.44TCr 2.69TCr 1,86000Cr 2.71TCr 19TCr 7.23TCr 94TCr 7.3TCr 7.14TCr 2,99600Cr | 1.18TCr 1.01TCr 954.74Cr 869.76Cr 1.63TCr 1,12500Cr 1.64TCr 11TCr 4.38TCr 57TCr 4.42TCr 4.32TCr 1,81200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $159.94 | +1.91% | 22,17,753 |
| 09/26/09 | $156.94 | -1.94% | 38,74,039 |
| 08/26/08 | $160.04 | -1.63% | 51,46,270 |
| 04/26/04 | $162.70 | -1.26% | 30,73,349 |
| 03/26/03 | $164.77 | +1.94% | 24,25,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
